Abstract:Genome sequencing (GS) has emerged as a powerful diagnostic tool in several patient populations. For example, in critically ill neonates, genetic disease often presents with few clinical features and disease progression can be rapid. Standard genetic testing strategies can take months or weeks to complete and many neonates die or are discharged before a diagnosis is obtained. Outside of China, application of rapid GS in critically ill infants has been shown to have both diagnostic and clinical utility. In this case report, we sought to determine the genetic etiology of a critically ill neonate using a novel 24-hour ultra-rapid GS protocol and to explore the clinical utility of the diagnosis. A critically ill male neonate was admitted to the Neonatal Intensive Care Unit (NICU) of Children's Hospital of Fudan University in June 2021 due to preterm birth (35+2 weeks gestation). He presented with edema, asphyxia, increased body weight and head circumference (> P97), hypoglycemia (0.8-1.1mmol/L), abnormal heart development, cardiac insufficiency and respiratory failure. Notably, fetal B-ultrasound performed at 6 months gestation showed polyhydramnios, large biparietal diameter and pleural effusion. On his fourth day of admission, 24-hour ultra-rapid GS was ordered and initiated at 2:00 PM. Blood samples were obtained from the patient and parents and sequencing was performed as previously described by our lab. To accelerate the data analysis process, we used the DRAGEN Bio-IT Platform as an all-in-one solution. A NovaSeq platform was used to generate the BCL files and output variant calling produced VCF files for single nucleotide variants (SNVs), small insertions and deletions (INDELs), copy number variants (CNVs), structural variants (SVs), and mitochondrial variants. Sequencing reads were aligned to the reference human genome (GRCh37/hg19). The process from BCL to FastQ was completed in 10 minutes. A bypass annotation and filtering process of SNVs, INDELs, and mitochondrial variants began when the VCFs for small variants were ready. This process occurred in parallel to variant calling for CNVs and SVs. Processing of VCFs for small variants took approximately 30 minutes for each sample, which were run separately on 3 servers. Annotation and filtering of small variants took approximately 30 minutes to complete and were then combined with CNV and SV results for manual interpretation. GS detected a heterozygous de novo pathogenic variant in the HRAS gene (NM_005343.4, c.35G>A, p.Gly12Asp) .The total time from sample collection to result delivery was 23.5 hours. Based on the GS results, the boy was diagnosed with Costello syndrome and, at the request of the parents, he was switched to a palliative support plan. For the family, genetic counselling been arranged to help guide their next reproductive planning. The all-in-one solution of BCL-FastQ-VCF process combined with parallel computing greatly shortened the bioinformatics pipeline. This case report represents the first successful execution of 24hr ultra-rapid GS in China. The pipeline provided a rapid and efficient method for determining the genetic etiology of a critically ill neonate and was conducive to early individualized management. There are additional cases being analyzed in our rapid pipeline so that more Chinese neonates will have the opportunity to benefit from this technology.

Application of Full-Spectrum Rapid Clinical Genome Sequencing Improves Diagnostic Rate and Clinical Outcomes in Critically Ill Infants in the China Neonatal Genomes Project*

[Application of the Artificial Intelligence-Rapid Whole-Genome Sequencing Diagnostic System in the Neonatal/pediatric Intensive Care Unit].

Clinical Practice of Whole-Genome Sequencing in the Rapid Diagnosis of Critically Ill Neonates

A Multicenter Prospective Study of Next-Generation Sequencing-Based Newborn Screening for Monogenic Genetic Diseases in China

An Integrated Pipeline for Trio‐Rapid Genome Sequencing in Critically Ill Infants

Application of Next-Generation Sequencing for Genetic Diagnosis in Neonatal Intensive Care Units: Results of a Multicenter Study in China

Optimized Trio Genome Sequencing (OTGS) As a First-Tier Genetic Test in Critically Ill Infants: Practice in China

Clinical utility of 24-h rapid trio-exome sequencing for critically ill infants

The Chinese Neonatal Network: a New Platform of National Collaboration on Quality Improvement for Preterm Infants

Secondary Genomic Findings in the 2020 China Neonatal Genomes Project Participants

Ep405: Clinical Application of 24-Hour Ultra-Rapid Genome Sequencing in a Critically Ill Neonate

Chinese Neonatal Network: a national protocol for collaborative research and quality improvement in neonatal care

Protocol of the China Neonatal Genomes Project: an observational study about genetic testing on 100,000 neonates

Diagnostic utility of rapid sequencing in critically ill infants: a systematic review and meta-analysis

National Rapid Genome Sequencing in Neonatal Intensive Care

Use of medical exome sequencing for identification of underlying genetic defects in NICU: Experience in a cohort of 2303 neonates in China

Newborn screening with targeted sequencing: a multicenter investigation and a pilot clinical study in China

Genetic Spectrums and Clinical Profiles of Critically Ill Neonates with Congenital Auricular Deformity in the China Neonatal Genomes Project

The China Neonatal Genomes Project(CNGP): New Advances in the Cohort Study of Genotype and Phenotype of Rare Diseases

Clinical Utility of Rapid Exome Sequencing Combined With Mitochondrial DNA Sequencing in Critically Ill Pediatric Patients With Suspected Genetic Disorders

Medical Exome As a First-Line Diagnostic Test in the Neonatal Intensive Care Unit: Experience in a Large Broad Cohort of 4,124 Neonates with Minimal Clinical Selection in China